Ebola virus DNA vaccine
Latest Information Update: 30 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Gene therapies
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Ebola virus infections
Most Recent Events
- 19 Feb 1998 Preclinical development for Ebola virus infections in USA (IM)
- 19 Feb 1998 New profile